RAPT Therapeutics, Inc. — Director's Dealing 2021

Feb 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-01-28

Reporting Person: Lam Karen C (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-28	Stock Option (right to buy)	$19.53	A	18000	Acquired	2031-01-27	Common Stock (18000)	Direct

Footnotes

F1: 1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting start date of January 1, 2021.